Brief: Aziyo Biologics Q2 Sales Rose 3.9 Percent To $12.6 Million

Elutia

11/08/2022 22:02

Aug 11 (Reuters) - Aziyo Biologics Inc  AZYO.O :
    * SEES FY SALES $47 MILLION TO $50 MILLION
    * Q2 SALES ROSE 3.9 PERCENT TO $12.6 MILLION
    * CONFIRMED ITS EXPECTATION THAT TOTAL NET SALES FOR FULL
YEAR
2022 WILL BE IN RANGE OF $47 MILLION TO $50 MILLION
    * Q2 LOSS PER SHARE $0.69

Source text for Eikon:  ID:nGNX2JXz6k 
Further company coverage:  AZYO.O 

 ((Reuters.Briefs@thomsonreuters.com;))